Cargando…

Tuning IL-2 signaling by ADP-ribosylation of CD25

Control of immunologic tolerance and homeostasis rely on Foxp3(+)CD4(+)CD25(+) regulatory T cells (Tregs) that constitutively express the high affinity receptor for Interleukin-2, CD25. Tregs proliferate in response to injections of IL-2/anti-IL-2 antibody complexes or low doses of IL-2. However, li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teege, Sophie, Hann, Alexander, Miksiewicz, Maria, MacMillan, Cary, Rissiek, Björn, Buck, Friedrich, Menzel, Stephan, Nissen, Marion, Bannas, Peter, Haag, Friedrich, Boyer, Olivier, Seman, Michel, Adriouch, Sahil, Koch-Nolte, Friedrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354014/ https://www.ncbi.nlm.nih.gov/pubmed/25753532 http://dx.doi.org/10.1038/srep08959

Ejemplares similares

ADP-Ribosylation Regulates the Signaling Function of IFN-γ
por: Menzel, Stephan, et al.
Publicado: (2021)

ADP-ribosylation of arginine
por: Laing, Sabrina, et al.
Publicado: (2010)

Alternative Splicing of the N-Terminal Cytosolic and Transmembrane Domains of P2X7 Controls Gating of the Ion Channel by ADP-Ribosylation
por: Schwarz, Nicole, et al.
Publicado: (2012)

P2X7 on Mouse T Cells: One Channel, Many Functions
por: Rissiek, Björn, et al.
Publicado: (2015)

Identification of the Mouse T Cell ADP-Ribosylome Uncovers ARTC2.2 Mediated Regulation of CD73 by ADP-Ribosylation
por: Leutert, Mario, et al.
Publicado: (2021)

Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia
por: Rissiek, Björn, et al.
Publicado: (2017)

Extracellular NAD(+) shapes the Foxp3(+) regulatory T cell compartment through the ART2–P2X7 pathway
por: Hubert, Sandra, et al.
Publicado: (2010)

In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs)
por: Otto, Helge, et al.
Publicado: (2005)

Extracellular NAD and ATP: Partners in immune cell modulation
por: Haag, Friedrich, et al.
Publicado: (2007)

T Cells of Different Developmental Stages Differ in Sensitivity to Apoptosis Induced by Extracellular NAD
por: Haag, Friedrich, et al.
Publicado: (2002)

Activation of the P2X7 ion channel by soluble and covalently bound ligands
por: Schwarz, Nicole, et al.
Publicado: (2009)

Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation
por: Möller, Sina, et al.
Publicado: (2007)

Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD(+) Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells
por: Baum, Natalie, et al.
Publicado: (2020)

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
por: Wesolowski, Janusz, et al.
Publicado: (2009)

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
por: Bannas, Peter, et al.
Publicado: (2015)

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity
por: Menzel, Stephan, et al.
Publicado: (2018)

Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
por: Bannas, Peter, et al.
Publicado: (2018)

Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo
por: Demeules, Mélanie, et al.
Publicado: (2022)

Reversing ADP-ribosylation
por: Moeller, Giuliana Katharina, et al.
Publicado: (2017)

Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs
por: Pinto-Espinoza, Carolina, et al.
Publicado: (2022)

Arginine-Specific Mono ADP-Ribosylation In Vitro of Antimicrobial Peptides by ADP-Ribosylating Toxins
por: Castagnini, Marta, et al.
Publicado: (2012)

Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling
por: Fontana, Pietro, et al.
Publicado: (2023)

Nanobodies as modulators of inflammation: potential applications for acute brain injury
por: Rissiek, Björn, et al.
Publicado: (2014)

Mouse CD38-Specific Heavy Chain Antibodies Inhibit CD38 GDPR-Cyclase Activity and Mediate Cytotoxicity Against Tumor Cells
por: Baum, Natalie, et al.
Publicado: (2021)

Reversible ADP-ribosylation of RNA
por: Munnur, Deeksha, et al.
Publicado: (2019)

The ADP-Ribosylating Toxins of Salmonella
por: Cheng, Rachel A., et al.
Publicado: (2019)

ADP-ribosylation of DNA and RNA()
por: Groslambert, Joséphine, et al.
Publicado: (2021)

ADP-ribosyl-N(3): A Versatile Precursor for Divergent Syntheses of ADP-ribosylated Compounds
por: Li, Lingjun, et al.
Publicado: (2017)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)

Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
por: Demeules, Mélanie, et al.
Publicado: (2020)

A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
por: Eden, Thomas, et al.
Publicado: (2018)

Origin, distribution, and function of three frequent coding polymorphisms in the gene for the human P2X7 ion channel
por: Schäfer, Waldemar, et al.
Publicado: (2022)

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019)

CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
por: Schütze, Kerstin, et al.
Publicado: (2018)

ADP-ribosylation of actin by clostridial toxins
Publicado: (1989)

ADP-Ribosylation: Activation, Recognition, and Removal
por: Li, Nan, et al.
Publicado: (2014)

The Promise of Proteomics for the Study of ADP-Ribosylation
por: Daniels, Casey M., et al.
Publicado: (2015)

Wnt pathway activation by ADP-ribosylation
por: Yang, Eungi, et al.
Publicado: (2016)

The coronavirus nucleocapsid protein is ADP-ribosylated
por: Grunewald, Matthew E., et al.
Publicado: (2018)

Computational and Experimental Studies of ADP-Ribosylation
por: Hammond, Robert G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mb2fv64van1lnehsqvg5967asa